相关实验视频

Updated: Jun 15, 2025

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

血友病B的基因疗法:来自1/2阶段101HEMB01/02研究的结果

Steven Pipe¹, Allen Poma², Anita Rajasekhar³

¹Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI.

|April 8, 2025

概括

使用DTX101治疗B型血友病的基因疗法显示不够的因子IX (FIX) 水平,需要辅助治疗. 从这项试验中吸取的教训可以为未来的血液疾病基因疗法开发提供信息.

科学领域:

遗传学和遗传性疾病
血液学血液学血液学
基因治疗基因治疗

背景情况:

血友病B是一种罕见的X相关出血疾病,由因子IX (FIX) 基因变异引起.
目前的标准护理包括预防,以保持FIX水平.
基因疗法为治疗B型血友病提供了一个潜在的替代方案.

研究的目的:

评估DTX101的安全性和有效性,一种基因疗法载体,在患有B型血友病的成年男性中.
在1/2期临床试验中确定DTX101的最佳剂量.
评估DTX101治疗的长期结果.

主要方法:

进行了1/2期,开放式,单臂,多中心研究 (101HEMB01) 和后续研究 (101HEMB02).
患有B型血友病的成年男性接受了DTX101的两种剂量水平 (1.6 × 10^12或5.0 × 10^12基因组拷贝/kg).
监测了安全性和有效性,包括血FIX水平和不良事件.

主要成果:

在第6周,在两个剂量队列中,FIX血水平的峰值低于20 IU/dL的目标值.
由于FIX活性不足,所有参与者都需要辅助FIX替代疗法.
与治疗相关的不良事件包括转氨酶水平升高和疲劳,这些是可以管理的.

结论:

由于治疗反应不足,DTX101基因治疗计划被停止.
这项研究为设计未来对B型血友病的基因治疗临床试验提供了宝贵的见解.
为未来的试验,建议优化转基因序列和免疫抑制协议.

更多相关视频

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...